Outcome | Exposure/insult | K | OR | 95% CI | P value | Heterogeneity | |||
Lower limit | Upper limit | I2 (%) | P value | ||||||
All BPD (BPD28) | Hypertensive disorders of pregnancy (HDP) | Any HDP | 13 | 0.927 | 0.636 | 1.352 | 0.695 | 62.8 | 0.001 |
Pre-eclampsia | 14 | 1.058 | 0.756 | 1.482 | 0.742 | 59.4 | 0.002 | ||
Pre-eclampsia/HELLP | 6 | 0.771 | 0.465 | 1.279 | 0.314 | 64.7 | 0.015 | ||
HDP overall | 33 | 0.949 | 0.757 | 1.188 | 0.645 | 61.9 | <0.001 | ||
SGA/IUGR | BW <P10 | 27 | 0.823 | 0.618 | 1.096 | 0.182 | 64.7 | <0.001 | |
BW <P3 or −2SD | 4 | 1.234 | 0.599 | 2.541 | 0.569 | 82.9 | 0.001 | ||
IUGR | 2 | 1.267 | 0.532 | 3.018 | 0.535 | 0.0 | 0.546 | ||
IUGR/SGA overall | 33 | 0.898 | 0.696 | 1.158 | 0.408 | 66.2 | <0.001 | ||
Moderate/severe BPD (BPD36) | HDP | Any HDP | 27 | 1.066 | 0.914 | 1.243 | 0.810 | 68.9 | <0.001 |
Pre-eclampsia | 31 | 1.093 | 0.869 | 1.375 | 0.448 | 83.8 | <0.001 | ||
Pre-eclampsia/HELLP | 3 | 1.022 | 0.762 | 1.372 | 0.882 | 75.8 | 0.017 | ||
HDP overall | 61 | 1.066 | 0.948 | 1.198 | 0.288 | 79.8 | <0.001 | ||
SGA/IUGR | BW <P10 | 57 | 1.550 | 1.308 | 1.837 | <0.001 | 85.7 | <0.001 | |
BW <P5 | 2 | 1.651 | 0.659 | 4.138 | 0.284 | 0.0 | 0.674 | ||
BW <P3 or −2SD | 23 | 1.460 | 1.130 | 1.884 | 0.004 | 87.8 | <0.001 | ||
IUGR | 9 | 2.251 | 1.537 | 3.297 | <0.001 | 80.0 | <0.001 | ||
SGA/IUGR overall | 91 | 1.564 | 1.369 | 1.785 | <0.001 | 85.5 | <0.001 | ||
Severe BPD | HDP | HDP overall* | 8 | 0.940 | 0.582 | 1.517 | 0.799 | 41.8 | 0.100 |
SGA/IUGR | BW <P10 | 11 | 1.491 | 1.001 | 2.220 | 0.049 | 34.5 | 0.123 | |
BW <P3 | 4 | 2.277 | 1.296 | 4.031 | 0.005 | 0.0 | 0.788 | ||
IUGR | 2 | 2.285 | 1.220 | 4.290 | 0.010 | 71.6 | 0.061 | ||
SGA/IUGR overall | 17 | 1.821 | 1.363 | 2.288 | <0.001 | 24.5 | 0.171 | ||
BPD or death | HDP | HDP overall* | 8 | 0.771 | 0.635 | 0.937 | 0.009 | 38.9 | 0.120 |
SGA/IUGR | BW <P10 | 12 | 1.792 | 1.387 | 2.315 | <0.001 | 90.5 | <0.001 | |
BW <P5 | 1 | 2.970 | 0.899 | 9.814 | 0.074 | 0.0 | 1.000 | ||
BW <P3 or −2SD | 2 | 2.538 | 1.323 | 4.869 | 0.005 | 54.1 | 0.140 | ||
IUGR | 3 | 1.934 | 1.126 | 3.323 | 0.017 | 87.7 | <0.001 | ||
SGA/IUGR overall | 18 | 1.914 | 1.545 | 2.373 | <0.001 | 88.7 | <0.001 | ||
BPD-associated pulmonary hypertension | HDP | Any HDP | 11 | 1.408 | 1.034 | 1.917 | 0.030 | 38.3 | 0.094 |
Pre-eclampsia | 9 | 1.418 | 0.944 | 2.128 | 0.092 | 0.0 | 0.554 | ||
HDP overall | 20 | 1.412 | 1.104 | 1.805 | 0.006 | 18.3 | 0.227 | ||
SGA/IUGR | BW <P10 | 17 | 2.275 | 1.771 | 2.922 | <0.001 | 40.8 | 0.041 | |
BW <P3 or −2SD | 3 | 4.418 | 1.689 | 11.556 | 0.002 | 0.0 | 0.390 | ||
SGA/IUGR overall | 20 | 2.373 | 1.862 | 3.023 | <0.001 | 38.7 | 0.040 |
Mixed effects analysis. A random effects model is used to combine studies within each subgroup. A fixed effect model is used to combine subgroups and yield the overall effect.
*Studies were not divided into subgroups because K<10 . OR >1 indicates association with increased risk of the outcome and OR <1 indicates association with decreased risk of the outcome.
BPD28, BPD defined as oxygen requirement on postnatal day 28; BPD36, BPD defined as oxygen requirement at the postmenstrual age of 36 weeks; BPD, bronchopulmonary dysplasia; BW, birth weight; IUGR, intrauterine growth restriction (defined on the basis of fetal growth assessment); K, number of studies; P3, third percentile; P5, 5th percentile; P10, 10th percentile; SGA, small for gestational age.